Fresenius Kabi Compounding Recalls Acyclovir Sodium Injection Due to Sterility Risks
Lack of Assurance of Sterility
1,320 recalls tagged with “fda regulated”.
Lack of Assurance of Sterility
Fresenius Kabi Compounding recalled 1,578 bags of vancomycin HCl injection on February 5, 2026. The company cited a lack of assurance of sterility as the reason for the recall. Healthcare providers and consumers should stop using the product immediately.
Fresenius Kabi Compounding recalled 1,410 bags of ketamine HCl injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers and consumers must stop using this product immediately.
Fresenius Kabi Compounding recalled 10,548 bags of thiamine HCl injection on February 5, 2026. The recall follows a lack of assurance of sterility, posing a high health risk. Affected products include several lots expiring between February and May 2026.
Remel, Inc. recalled 97 units of Campy CVA Medium on February 5, 2026. Customers reported low to no recovery of Campylobacter Jejuni ATCC 33291 in the affected lot. Healthcare providers and patients must stop using the product immediately.
There is a potential issue that can lead to discordance between the simulated needle trajectory/tip position and the actual needle trajectory/tip position.
Impactor handle may be missing cross-pin
Impactor handle may be missing cross-pin
Prime Food Processing recalled 79 cases of dried croaker fish on February 3, 2026, due to safety concerns. The uneviscerated fish poses a high risk of food poisoning. Consumers should not consume this product and seek refunds.
The potential for the needle tip to be dull/blunt, difficult to advance, and/or break.
The potential for the needle tip to be dull/blunt, difficult to advance, and/or break.
Due to complaints and investigations stating that alarms from the primary patient bedside monitor was not alarming/being transmitted and received on the remote patient monitoring system.
The instructions for use (IFUs) on specified Cardinal Health Chest Drainage Units (CDUs) and accessories have been updated to clarify the intended target patient population as adults, 18 years and older.
Due to firm distributing a nonconforming product that supposed to be scrapped and not for human use.
Due to firm distributing a nonconforming product that supposed to be scrapped and not for human use.